These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2492706)

  • 1. Simultaneous inhibition by pirenzepine of the GH responses to GnRH and TRH in insulin-dependent diabetics and in patients with major depression.
    Coiro V; Volpi R; Capretti L; Speroni G; Castelli A; Mosti A; Marchesi C; Gardini E; Rossi G; Chiodera P
    Acta Endocrinol (Copenh); 1989 Feb; 120(2):143-8. PubMed ID: 2492706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics involves a cholinergic mechanism.
    Chiodera P; Coiro V; Speroni G; Capretti L; Muzzetto P; Volpi R; Butturini U
    J Clin Endocrinol Metab; 1984 Oct; 59(4):794-7. PubMed ID: 6434581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pirenzepine inhibits growth hormone, but not thyrotropin response to thyrotropin-releasing hormone in patients with endogenous depression.
    Coiro V; Marchesi C; De Ferri A; Mosti A; Delsignore R; Govi AM; Gnudi A; Chiodera P
    Psychoneuroendocrinology; 1987; 12(4):313-7. PubMed ID: 3116574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-releasing hormone inhibition of paradoxical growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics.
    Barbarino A; Corsello SM; Tofani A; Sciuto R; Della Casa S; Rota CA; Colasanti S; Barini A
    Metabolism; 1992 Sep; 41(9):949-53. PubMed ID: 1355581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic mediation of growth hormone secretion induced by thyrotropin-releasing hormone in cirrhotic patients.
    Volpi R; Chiodera P; Cerri L; Roberti G; Salati G; Ferrari P; Delsignore R; Pedretti G; d'Amato L; Coiro V
    Acta Endocrinol (Copenh); 1987 Apr; 114(4):603-8. PubMed ID: 3107300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinergic muscarinic receptor blockade suppresses arginine- and exercise-induced growth hormone secretion in type I diabetic subjects.
    Arends J; Wagner ML; Willms BL
    J Clin Endocrinol Metab; 1988 Feb; 66(2):389-94. PubMed ID: 3339112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced sensitivity to pirenzepine-induced blockade of growth hormone responses to arginine, exercise, and growth hormone-releasing hormone in type I diabetic subjects.
    Coiro V; Passeri M; Gardini E; Capretti L; Speroni G; Davoli C; Maffei ML; Fagnoni F; Bianconi L; Volpi R
    Metabolism; 1990 Jul; 39(7):668-75. PubMed ID: 2114512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone responses to the releasing hormones GHRH and GnRH and the inhibitors somatostatin and bromocriptine in TRH-responsive and non-responsive acromegalics.
    Smals AE; Pieters GF; Smals AG; Hermus AR; Benraad TJ; Kloppenborg PW
    Acta Endocrinol (Copenh); 1987 Sep; 116(1):53-8. PubMed ID: 2889308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of effect of muscarinic cholinergic blockade on the GH responses to GRF 1-29 and TRH in acromegalic subjects.
    Jordan V; Dieguez C; Valcavi R; Artioli C; Portioli I; Rodriguez-Arnao MD; Gomez-Pan A; Hall R; Scanlon MF
    Clin Endocrinol (Oxf); 1986 Apr; 24(4):415-20. PubMed ID: 2874906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of growth hormone (GH) response to GHRH in diabetes mellitus type 1 after blockade of the cholinergic system with pirenzepine].
    Krassowski J; Rogala H; Jeske W; Zgliczyński S
    Pol Arch Med Wewn; 1992 Jul; 88(1):25-9. PubMed ID: 1454656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histamine-induced paradoxical GH response to TRH/GnRH in men and women: dependence on gonadal steroid hormones.
    Knigge U; Thuesen B; Dejgaard A; Svenstrup B; Bennett P
    Acta Endocrinol (Copenh); 1990 Mar; 122(3):354-60. PubMed ID: 2109444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone response to thyrotropin releasing hormone and placebo in a group of insulin dependent diabetic patients.
    Valentini U; Cimino A; Rotondi A; Rocca L; Pelizzari R; Giustina A; Marchetti C; Romanelli G
    J Endocrinol Invest; 1989 Oct; 12(9):643-6. PubMed ID: 2511239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intravenous TRH on growth hormone and cortisol serum levels in children and adolescents with insulin dependent diabetes mellitus.
    Vanelli M; Bernasconi S; Bolondi O; Mamì C; Pandullo E; Scaffidi M; Siracusano MF; De Luca F
    J Endocrinol Invest; 1986 Aug; 9(4):293-7. PubMed ID: 3097114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone response to a novel growth hormone-releasing tripeptide in horses: interaction with gonadotropin-releasing hormone, thyrotropin-releasing hormone, and sulpiride.
    Kennedy SR; Thompson DL; Pruett HE; Burns PJ; Deghenghi R
    J Anim Sci; 2002 Mar; 80(3):744-50. PubMed ID: 11890411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-specific response of serum growth hormone to thyrotropin-releasing hormone in diabetics.
    Pan CY; Lu JM; Chang XM; Luo GC; Li H
    Chin Med J (Engl); 1989 Jan; 102(1):41-4. PubMed ID: 2504551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-specific pituitary responses in insulin-dependent diabetes mellitus in children and adolescents].
    Iughetti L; Petraglia F; Facchinetti F; Genazzani AR; Cozzini A; Vanelli M; Bernasconi S
    Presse Med; 1995 Dec 16-23; 24(39):1894-8. PubMed ID: 8745537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotropin-releasing hormone (TRH) does not suppress growth hormone response to L-dopa in insulin-dependent diabetes mellitus.
    Krassowski J; Jeske W; Zgliczyński S
    Endokrynol Pol; 1992; 43(3):344-8. PubMed ID: 1345575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic involvement in the growth hormone releasing hormone-induced growth hormone release: studies in normal and acromegalic subjects.
    Massara F; Ghigo E; Demislis K; Tangolo D; Mazza E; Locatelli V; Müller EE; Molinatti GM; Camanni F
    Neuroendocrinology; 1986; 43(6):670-5. PubMed ID: 3093909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cholinergic muscarinic receptor blockade on human growth hormone (GH)-releasing hormone-(1-44)-induced GH secretion in anorexia nervosa.
    Tamai H; Komaki G; Matsubayashi S; Kobayashi N; Mori K; Nakagawa T; Truong MP; Walter RM; Kumagai LF
    J Clin Endocrinol Metab; 1990 Mar; 70(3):738-41. PubMed ID: 2106528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The frequency and amplitude of growth hormone secretory episodes as determined by deconvolution analysis are increased in adolescents with insulin dependent diabetes mellitus and are unaffected by short-term euglycaemia.
    Pal BR; Matthews DR; Edge JA; Mullis PE; Hindmarsh PC; Dunger DB
    Clin Endocrinol (Oxf); 1993 Jan; 38(1):93-100. PubMed ID: 8435890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.